dc.contributor.editor |
Dr. Anders Gram (Novozymes A/S, Denmark); Dr. Wiltrud Treffenfeldt (Dow, Germany); Dr. Ulf Lange
(BMBF, Germany); Dr. Terry McIntyre (Environment Canada, Canada); Mr. Oliver Wolf (European
Commission/JRC/IPTS, Spain). OECD support was provided by Dr. Salomon Wald (Head of
Biotechnology Unit) and Dr. Yoshiyasu Yabusaki of the OECD Directorate for Science |
|
dc.description |
The present study seeks to answer these questions on the basis of the experience of a number of
companies that analysed the potential of biotechnology and decided to adopt or reject a biotechnology
process. It is based on a collection of 21 case studies, which are presented in a broadly similar format so
that readers can easily compare one application with another. All the available cases have been taken
into account, though not all reflect successful application of a new technology. Two major types of
biotechnology applications are covered, the use of renewable resources (“biomass”) and the use of
biosystems (biocatalysts, enzymes) in industrial processes.
A very wide range of industrial sectors is represented: pharmaceuticals, fine chemicals, bulk
chemicals, food and feed, textiles, pulp and paper, minerals and energy. The range of countries is also
wide: Austria, Canada, Germany, Japan, the Netherlands, the United Kingdom, the United States and
South Africa. |
|